| GENE_SYMBOL |
HGNC_ID |
UNIPROT_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| ADRA2A |
HGNC:281 |
P08913 |
2-[4-(4-Fluorophenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine |
1248739 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)-, monohydrochloride |
3038494 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- |
3038495 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4,5-dihydro-1H-imidazol-2-amine |
3086247 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine |
4350931 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
2-[[4-(2-Methoxyphenyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridine |
6469693 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
2-{[4-(4-Chlorophenyl)piperazin-1-yl]methyl}imidazo[1,2-a]pyridine |
6469918 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
Ro 25-6981 |
6604887 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
Vilazodone |
6918314 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
2-[4-[(4-Chlorophenyl)methyl]piperazin-1-yl]-1-(2,3-dihydroindol-1-yl)ethanone |
9104271 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
(4-tert-Butyl-3-methoxy-2,6-dimethyl-phenyl)-(1H-imidazol-2-yl)-amine |
9795515 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
1-(2-Methyl-2,3-dihydroindol-1-yl)-2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]ethanone |
9799123 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
5-Methoxy-3-{4-[4-(4-methoxy-phenyl)-piperazin-1-yl]-butyl}-1H-indole |
9800737 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
1-{2-[4-(6-Fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-yl]-ethyl}-isochroman-6-carboxylic acid amide |
9802187 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
[2-(3,4-Dihydro-1H-isoquinolin-2-yl)-pyridin-4-yl]-methyl-amine |
9813501 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
Imidazolidin-2-ylidene-(5-methyl-1,2,3,4-tetrahydro-quinoxalin-6-yl)-amine |
9816048 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
2-((2-(3,4-Dihydroisoquinolin-2(1H)-yl)pyridin-4-yl)amino)ethanol |
9816863 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-{1-[2-(1H-Indol-4-yloxy)-ethyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1H-pyrrolo[2,3-b]pyridine |
9820163 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
3-[4-(4-Benzo[1,3]dioxol-5-yl-piperazin-1-yl)-butyl]-1H-indole-5-carboxylic acid amide |
9823464 |
TTD |
| ADRA2A |
HGNC:281 |
P08913 |
Imidazolidin-2-ylidene-(5-methyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-amine |
9837551 |
TTD |